Cargando…
Assessing hERG Pore Models As Templates for Drug Docking Using Published Experimental Constraints: The Inactivated State in the Context of Drug Block
[Image: see text] Many structurally and therapeutically diverse drugs interact with the human heart K(+) channel hERG by binding within the K(+) permeation pathway of the open channel, leading to drug-induced ‘long QT syndrome’. Drug binding to hERG is often stabilized by inactivation gating. In the...
Autores principales: | Dempsey, Christopher E., Wright, Dominic, Colenso, Charlotte K., Sessions, Richard B., Hancox, Jules C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977586/ https://www.ncbi.nlm.nih.gov/pubmed/24471705 http://dx.doi.org/10.1021/ci400707h |
Ejemplares similares
-
Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking
por: Zhang, Yihong, et al.
Publicado: (2016) -
Ranolazine inhibition of hERG potassium channels: Drug–pore interactions and reduced potency against inactivation mutants
por: Du, Chunyun, et al.
Publicado: (2014) -
Voltage Sensor Gating Charge Transfer in a hERG Potassium Channel Model
por: Colenso, Charlotte K., et al.
Publicado: (2014) -
The hERG K(+) channel S4 domain L532P mutation: Characterization at 37 °C
por: Zhang, Yi H., et al.
Publicado: (2011) -
Electrophysiological characterization of the modified hERG(T) potassium channel used to obtain the first cryo‐EM hERG structure
por: Zhang, Yihong, et al.
Publicado: (2020)